Considering the significant association that we found between CLR expression and the infiltration of various immune cells in the microenvironment, we can speculate that CLRs may also regulate the expression and function of immune cells in bladder cancer by regulating the secretion and alteration of chemokines. Here, LARS1 is linked to urinary bladder carcinoma.